This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of Xiaohua Li in Antidiabetic Research
Introduction
Xiaohua Li is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of diabetes treatment through his innovative research and patenting efforts. His work focuses on the development of compounds that can potentially improve insulin response and production.
Latest Patents
Xiaohua Li holds a patent for "Antidiabetic 4-hydroxy-2-furoic acids." This patent describes the process of obtaining substituted 4-hydroxy-2-furoic acids through the fermentation of an asterriquinone, a natural product with a unique 2,5-dioxy-3,6-bis(indolyl)quinone structure. The compounds developed from this research are designed to modulate insulin receptor tyrosine kinase activity, which may be beneficial in treating diabetes and other conditions associated with impaired insulin production or response.
Career Highlights
Xiaohua Li is currently employed at Merck & Company, Inc., where he continues to advance his research in the pharmaceutical field. His work has the potential to impact the lives of many individuals suffering from diabetes and related health issues.
Collaborations
Some of Xiaohua Li's coworkers include Shieh-Shung T Chen and Bei B Zhang, who contribute to the collaborative efforts in research and development within their organization.
Conclusion
Xiaohua Li's innovative work in antidiabetic research exemplifies the importance of scientific advancements in healthcare. His contributions through patenting and collaboration highlight the ongoing efforts to improve treatment options for diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile